Related Experiment Videos

Emerging roles of DMP1 in lung cancer

Kazushi Inoue1, Takayuki Sugiyama, Pankaj Taneja

  • 1Departments of Pathology and Cancer Biology, Wake Forest University Health Sciences, Medical Center Boulevard, Winston-Salem, North Carolina, USA. kinoue@wfubmc.edu

Cancer Research
|June 19, 2008
PubMed

Insights

Loss of the DMP1 gene, a transcription factor, promotes lung cancer by disrupting the Arf/p53 tumor suppressor pathway. This suggests DMP1 alterations may have prognostic value in human cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The transcription factor DMP1 activates Arf, which promotes p53-dependent cell cycle arrest.
  • Loss of tumor suppressor function is a key mechanism in cancer development.

Purpose of the Study:

  • To investigate the role of DMP1 in lung cancer development and its association with the Arf/p53 pathway.
  • To explore the pathophysiologic significance of DMP1 in human lung cancers.

Main Methods:

  • Identification of DMP1 loss in human lung cancer samples.
  • Analysis of Dmp1 gene deletion in mouse models of K-ras-induced lung tumorigenesis.

Main Results:

  • DMP1 loss was identified in human lung cancers lacking ARF/p53 mutations.
  • Dmp1 deletion in mice promoted K-ras-induced lung tumorigenesis.
  • These effects were consistent with a disruption of Arf/p53 suppressor function.

Conclusions:

  • DMP1 alterations are significant in lung cancer pathogenesis.
  • DMP1 inactivation cooperates with oncogenic events like K-ras.
  • Further research into DMP1's prognostic value and cooperative oncogenic events is warranted.